logologo
QuantliQuantli

Minerva Neurosciences Inc

NERV

NASDAQ

Biotechnology

$4.58

USD

+0.66 (+16.84%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $187.17M

Volume 340.0K

Price Target

$10.00$10.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $10.00 and a min estimate of $10.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$10.00

-$0.5 vs prior

Implied Upside

+118.3%

-10.9% vs prior

Analyst Covering

1

-1 vs prior period

Consensus

Buy

Improved vs prior

Signal Quality

Consensus Freshness

33%

Many ratings are older - consensus may be less current

Analyst Agreement

High

Targets are closely clustered - analysts agree more than usual

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Biren Amin

Piper Sandler

Buy

Upgraded

1 day ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

PEPG

PepGen Inc

$2.99

+0.3%

ALEC

Alector Inc

$1.96

-3.9%

WHWK

Whitehawk Therapeutics Inc

$4.46

-4.7%

NBP

NovaBridge Biosciences

$1.96

+3.2%

IVVD

Invivyd Inc

$0.7200

+5.1%

TNXP

Tonix Pharmaceuticals Holding Corp

$12.71

+1.7%

DTIL

Precision BioSciences Inc

$7.43

+1.8%

RNA

Atrium Therapeutics Inc

$12.84

+4.1%

IMUX

Immunic Inc

$16.06

-3.1%